Narrative review: The systemic capillary leak syndrome

Annals of Internal Medicine

Volumn 153, Issue 2, 2010, Pages 90-98

  Druey, Kirk M ^a   Greipp, Philip R ^b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b Mayo Clinic College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; BORTEZOMIB; CORTICOSTEROID; DASATINIB; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPERTENSIVE FACTOR; IMATINIB; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; INFLIXIMAB; LENALIDOMIDE; MELPHALAN; PREDNISONE; PROSTACYCLIN; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RITUXIMAB; TERBUTALINE; THALIDOMIDE; THEOPHYLLINE;

ACUTE DISEASE; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; CAPILLARY LEAK SYNDROME; COLLAPSE; COLLOID; COMPARTMENT SYNDROME; EDEMA; ENDOTHELIAL DYSFUNCTION; EXTRAVASATION; FATIGUE; FLUID THERAPY; HEMATOCRIT; HEMOCONCENTRATION; HUMAN; HYPOALBUMINEMIA; HYPOTENSION; ISCHEMIA; LUNG EDEMA; MYALGIA; PRIORITY JOURNAL; PROGNOSIS; RARE DISEASE; REVIEW; RHABDOMYOLYSIS; SEPSIS; SHOCK; SURVIVAL RATE; VENOUS THROMBOEMBOLISM; WEAKNESS; DIFFERENTIAL DIAGNOSIS; PATHOPHYSIOLOGY;

CAPILLARY LEAK SYNDROME; DIAGNOSIS, DIFFERENTIAL; HUMANS; PROGNOSIS;

EID: 77955302960     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-153-2-201007200-00005     Document Type: Review

References (90)

1. Atkinson JP, Waldmann TA, Stein SF, Gelfand JA, Macdonald WJ, Heck LW, et al. Systemic capillary leak syndrome and monoclonal IgG gammopathy; studies in a sixth patient and a review of the literature. Medicine (Baltimore). 1977;56:225-39. [PMID: 870792]
2. Noble RP, Gregersen MI, Porter PM, Buckman A. Blood volume in clinical shock. II. The extent and cause of blood volume reduction in traumatic, hemorrhagic, and burn shock. J Clin Invest. 1946;25:172-83. [PMID: 16695306]
3. Tahirkheli NK, Greipp PR. Treatment of the systemic capillary leak syndrome with terbutaline and theophylline. A case series. Ann Intern Med. 1999;130:905-9. [PMID: 10375339]
4. Kawabe S, Saeki T, Yamazaki H, Nagai M, Aoyagi R, Miyamura S. Systemic capillary leak syndrome. Intern Med. 2002;41:211-5. [PMID: 11929183]
5. Dhir V, Arya V, Malav IC, Suryanarayanan BS, Gupta R, Dey AB. Idiopathic systemic capillary leak syndrome (SCLS): case report and systematic review of cases reported in the last 16 years. Intern Med. 2007;46:899-904. [PMID: 17575386]
6. Gousseff M, Amoura Z. [Idiopathic capillary leak syndrome]. Rev Med Interne. 2009;30:754-68. [PMID: 19615793]
7. Sion-Sarid R, Lerman-Sagie T, Blumkin L, Ben-Ami D, Cohen I, Houri S. Neurologic involvement in a child with systemic capillary leak syndrome. Pediatrics. 2010;125:e687-92. [PMID: 20123768]
8. Lambert M, Launay D, Hachulla E, Morell-Dubois S, Soland V, Queyrel V, et al. High-dose intravenous immunoglobulins dramatically reverse systemic capillary leak syndrome. Crit Care Med. 2008;36:2184-7. [PMID: 18552679]
9. Keller KK, Hauge EM, Stengaard-Pedersen K. Chronic systemic capillary leak syndrome: a case responding to prednisolone treatment [Letter]. Scand J Rheumatol. 2009;38:400-1. [PMID: 20166237]
10. Onal H, Aktuglu-Zeybek C, Altun G, Ozyilmaz I, Alhaj S, Aydin A. Capillary leak syndrome in a 5-month-old infant associated with intractable diarrhoea. Ann Trop Paediatr. 2007;27:81-6. [PMID: 17469737]
11. Lesterhuis WJ, Rennings AJ, Leenders WP, Nooteboom A, Punt CJ, Sweep FC, et al. Vascular endothelial growth factor in systemic capillary leak syndrome. Am J Med. 2009;122:e5-7. [PMID: 19486705]
12. De Martino M, Sasso L, Pirozzi F, Bonaduce D. Systemic capillary leak syndrome or Clarkson's disease: a case report [Letter]. Intern Emerg Med. 2009;4:357-8. [PMID: 19526356]
13. Dowden AM, Rullo OJ, Aziz N, Fasano MB, Chatila T, Ballas ZK. Idiopathic systemic capillary leak syndrome: novel therapy for acute attacks [Letter]. J Allergy Clin Immunol. 2009;124:1111-3. [PMID: 19703708]
14. Lee YS, Kim SY, Kwon CW, Song HG, Lee YK, Kim HJ, et al. Two cases of systemic capillary leak syndrome that were treated with pentastarch. Korean J Intern Med. 2007;22:130-2. [PMID: 17616032]
15. Perry J, Balasubramanian S, Imray C. Systemic capillary leak syndrome resulting in compartment syndrome and the requirement for a surgical airway. Anaesthesia. 2009;64:679-82. [PMID: 19453323]
16. Solomon S, Pefanis A, Papaetis GS, Ginos C, Kythreotis P, Achimastos A. A patient with recurrent episodes of abdominal pain and hypovolemic shock. Am J Emerg Med. 2009;27:755.e5-7. [PMID: 19751646]
17. Ingegnoli F, Sciascera A, D'Ingianna E, Fantini F. Systemic sclerosis, capillary leak syndrome and nasopharyngeal carcinoma: an unusual association or paraneoplastic manifestations? [Letter]. Rheumatology (Oxford). 2009;48:201-2. [PMID: 19052056]
18. Kjaergaard KD, Rickers H. [Systemic capillary leak syndrome]. Ugeskr Laeger. 2008;170:3251. [PMID: 18940160]
19. Dams K, Meersseman W, Verbeken E, Knockaert DC. A 59-year-old man with shock, polycythemia, and an underlying paraproteinemia. Chest. 2007;132:1393-6. [PMID: 17934127]
20. Matsumura M, Kakuchi Y, Hamano R, Kitajima S, Ueda A, Kawano M, et al. Systemic capillary leak syndrome associated with compartment syndrome. Intern Med. 2007;46:1585-7. [PMID: 17878647]
21. Mosadik A, Kettani A, Faroudy M, Sbihi A. [Idiopathic capillary leak syndrome: an exceptional aetiology for shock] [Letter]. Ann Fr Anesth Reanim. 2007;26:715-6. [PMID: 17574370]
22. Bonadies N, Baud P, Peter HJ, Buergi U, Mueller BU. A case report of Clarkson's disease: If you don't know it, you'll miss it. Eur J Intern Med. 2006;17:363-5. [PMID: 16864014]
23. Sanghavi R, Aneman A, Parr M, Dunlop L, Champion D. Systemic capillary leak syndrome associated with compartment syndrome and rhabdomyolysis. Anaesth Intensive Care. 2006;34:388-91. [PMID: 16802499]
24. Hollenberg J, Frykman J, Lundberg LG, Forsberg S. A case report of systemic capillary leak syndrome (Clarkson's disease). Acta Anaesthesiol Scand. 2010;54:649-52. [PMID: 20148770]
25. Lions C, Wey PF, Puidupin M, Soubirou JL, Escarment J. [Haemodynamic management of Clarkson's disease: interest of the echocardiographic follow-up] [Letter]. Ann Fr Anesth Reanim. 2007;26:1079-81. [PMID: 17964113]
26. Debourdeau P, Bory P, Zammit C, Pavic M, Colle B. [Recurrent unexplained lipothymia: do not forget the capillary leak syndrome]. Rev Med Interne. 2007;28:711-3. [PMID: 17321012]
27. Foeldvari I, Waida E, Junker AK. Systemic capillary leak syndrome in a child. J Pediatr. 1995;127:739-41. [PMID: 7472826]
28. Karatzios C, Gauvin F, Egerszegi EP, Tapiero B, Buteau C, Rivard GE, et al. Systemic capillary leak syndrome presenting as recurrent shock. Pediatr Crit Care Med. 2006;7:377-9. [PMID: 16738498]
29. Cicardi M, Gardinali M, Bisiani G, Rosti A, Allavena P, Agostoni A. The systemic capillary leak syndrome: appearance of interleukin-2-receptor-positive cells during attacks. Ann Intern Med. 1990;113:475-7. [PMID: 2386338]
30. Cicardi M, Berti E, Caputo V, Radice F, Gardinali M, Agostoni A. Idiopathic capillary leak syndrome: evidence of CD8-positive lymphocytes surrounding damaged endothelial cells. J Allergy Clin Immunol. 1997;99:417-9. [PMID: 9058699]
31. Fellows IW, Powell RJ, Toghill PJ, Williams TJ, Cohen GF. Epoprostenol in systemic capillary leak syndrome [Letter]. Lancet. 1988;2:1143. [PMID: 2903357]
32. Weinbren I. Spontaneous periodic oedema. A new syndrome. Lancet. 1963;2:544-6. [PMID: 14049581]
33. Kao NL, Richmond GW, Luskin AT. Systemic capillary leak syndrome [Letter]. Chest. 1993;104:1637-8. [PMID: 8222853]
34. Horwith M, Hagstrom JW, Riggins RC, Luckey EH. Hypovolemic shock and edema due to increased capillary permeability. JAMA. 1967;200:101-4. [PMID: 6071375]
35. Fardet L, Kerob D, Rybojad M, Vignon-Pennamen MD, Schlemmer B, Guermazi A, et al. Idiopathic systemic capillary leak syndrome: cutaneous involvement can be misleading. Dermatology. 2004;209:291-5. [PMID: 15539891]
36. Jacox RF, Waterhouse C, Tobin R. Periodic disease associated with muscle destruction. Am J Med. 1973;55:105-10. [PMID: 4123734]
37. Doubek M, Brychtova Y, Tomiska M, Mayer J. Idiopathic systemic capillary leak syndrome misdiagnosed and treated as polycythemia vera. Acta Haematol. 2005;113:150-1. [PMID: 15802896]
38. Navarro C, García-Bragado F, Lima J, Fernández JM. Muscle biopsy findings in systemic capillary leak syndrome. Hum Pathol. 1990;21:297-301. [PMID: 2179110]
39. Johansson BR, Löfdahl CG. Ultrastructure of the microvessels in skeletal muscle in a case of systemic capillary leak syndrome. Acta Med Scand. 1979;206:413-6. [PMID: 525443]
40. Assaly R, Olson D, Hammersley J, Fan PS, Liu J, Shapiro JI, et al. Initial evidence of endothelial cell apoptosis as a mechanism of systemic capillary leak syndrome. Chest. 2001;120:1301-8. [PMID: 11591575]
41. van Hinsbergh V, van Nieuw Amerongen G. Intracellular signalling involved in modulating human endothelial barrier function. J Anat. 2002;200:525. [PMID: 17103720]
42. Gavard J, Gutkind JS. VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat Cell Biol. 2006;8:1223-34. [PMID: 17060906]
43. Huang X, Wu D, Jin H, Stupack D, Wang JY. Induction of cell retraction by the combined actions of Abl-CrkII and Rho-ROCK1 signaling. J Cell Biol. 2008;183:711-23. [PMID: 19001122]
44. van Nieuw Amerongen GP, Koolwijk P, Versteilen A, van Hinsbergh VW. Involvement of RhoA/Rho kinase signaling in VEGF-induced endothelial cell migration and angiogenesis in vitro. Arterioscler Thromb Vasc Biol. 2003;23:211-7. [PMID: 12588761]
45. van Nieuw Amerongen GP, van Hinsbergh VW. Targets for pharmacological intervention of endothelial hyperpermeability and barrier function. Vascul Pharmacol. 2002;39:257-72. [PMID: 12747965]
46. Noda K, Zhang J, Fukuhara S, Kunimoto S, Yoshimura M, Mochizuki N. Vascular endothelial-cadherin stabilizes at cell-cell junctions by anchoring to circumferential actin bundles through alpha- and beta-Catenins in cyclic AMP-Epac-Rap1 signal-activated endothelial cells. Mol Biol Cell. 2010;21:584-96. [PMID: 20032304]
47. Chihara R, Nakamoto H, Arima H, Moriwaki K, Kanno Y, Sugahara S, et al. Systemic capillary leak syndrome. Intern Med. 2002;41:953-6. [PMID: 12487166]
48. Ebihara I, Hirayama K, Kaneko S, Nagai M, Ogawa Y, Fujita S, et al. Vascular endothelial growth factor and soluble fms-like tyrosine kinase-1 in septic shock patients treated with direct hemoperfusion with a polymyxin B-immobilized fiber column. Ther Apher Dial. 2008;12:285-91. [PMID: 18789115]
49. Albert C, Garrido N, Mercader A, Rao CV, Remohí J, Simón C, et al. The role of endothelial cells in the pathogenesis of ovarian hyperstimulation syndrome. Mol Hum Reprod. 2002;8:409-18. [PMID: 11994537]
50. Dispenzieri A, Moreno-Aspitia A, Suarez GA, Lacy MQ, Colon-Otero G, Tefferi A, et al. Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literature. Blood. 2004;104:3400-7. [PMID: 15280195]
51. Kumar S, Witzig TE, Timm M, Haug J, Wellik L, Fonseca R, et al. Expression of VEGF and its receptors by myeloma cells. Leukemia. 2003;17: 2025-31. [PMID: 14513053]
52. Rajkumar SV, Dispenzieri A, Kyle RA. Monoclonal gammopathy of undetermined significance, Waldenström macroglobulinemia, AL amyloidosis, and related plasma cell disorders: diagnosis and treatment. Mayo Clin Proc. 2006;81:693-703. [PMID: 16706268]
53. Vigneau C, Haymann JP, Khoury N, Sraer JD, Rondeau E. An unusual evolution of the systemic capillary leak syndrome. Nephrol Dial Transplant. 2002;17:492-4. [PMID: 11865098]
54. Hiraoka E, Matsushima Y, Inomoto-Naribayashi Y, Nakata H, Nakamura A, Kawanami C, et al. Systemic capillary leak syndrome associated with multiple myeloma of IgG kappa type. Intern Med. 1995;34:1220-4. [PMID: 8929655]
55. Ghosh K, Madkaikar M, Iyer Y, Pathare A, Jijina F, Mohanty D. Systemic capillary leak syndrome preceding plasma cell leukaemia. Acta Haematol. 2001;106:118-21. [PMID: 11713377]
56. Beermann W, Hörstrup KA, Will R. Systemic capillary leak syndrome [Letter]. Am J Med. 1998;105:554. [PMID: 9870846]
57. Zhang W, Ewan PW, Lachmann PJ. The paraproteins in systemic capillary leak syndrome. Clin Exp Immunol. 1993;93:424-9. [PMID: 8370170]
58. Zivković SA, Lacomis D, Lentzsch S. Paraproteinemic neuropathy. Leuk Lymphoma. 2009;50:1422-33. [PMID: 19637090]
59. Merlini G, Stone MJ. Dangerous small B-cell clones. Blood. 2006;108:2520-30. [PMID: 16794250]
60. Michiels JJ, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, Budde U, et al. Immune-mediated etiology of acquired von Willebrand syndrome in systemic lupus erythematosus and in benign monoclonal gammopathy: therapeutic implications. Semin Thromb Hemost. 2006;32:577-88. [PMID: 16977568]
61. Rizzi R, Curci P, Rinaldi E, Rinaldi F, Cimmino A, Ricco R, et al. Schnitzler's syndrome: monoclonal gammopathy associated with chronic urticaria. Acta Haematol. 2008;120:1-4. [PMID: 18612198]
62. Cugno M, Castelli R, Cicardi M. Angioedema due to acquired C1-inhibitor deficiency: a bridging condition between autoimmunity and lymphoproliferation. Autoimmun Rev. 2008;8:156-9. [PMID: 19014872]
63. Amoura Z, Papo T, Ninet J, Hatron PY, Guillaumie J, Piette AM, et al. Systemic capillary leak syndrome: report on 13 patients with special focus on course and treatment. Am J Med. 1997;103:514-9. [PMID: 9428835]
64. Airaghi L, Montori D, Santambrogio L, Miadonna A, Tedeschi A. Chronic systemic capillary leak syndrome. Report of a case and review of the literature. J Intern Med. 2000;247:731-5. [PMID: 10886496]
65. Stirling CM, Boulton-Jones JM, Simpson K. Progressive oedema in a 30-year-old. Lancet. 1998;352:450. [PMID: 9708754]
66. Gleich GJ, Leiferman KM. The hypereosinophilic syndromes: current concepts and treatments. Br J Haematol. 2009;145:271-85. [PMID: 19243381]
67. Dolberg-Stolik OC, Putterman C, Rubinow A, Rivkind AI, Sprung CL. Idiopathic capillary leak syndrome complicated by massive rhabdomyolysis. Chest. 1993;104:123-6. [PMID: 8325053]
68. Droder RM, Kyle RA, Greipp PR. Control of systemic capillary leak syndrome with aminophylline and terbutaline. Am J Med. 1992;92:523-6. [PMID: 1580299]
69. Doorenbos CJ, van Es A, Valentijn RM, van Es LA. Systemic capillary leak syndrome. Preventive treatment with terbutaline. Neth J Med. 1988;32:178-84. [PMID: 3362269]
70. Charlton SJ. Agonist efficacy and receptor desensitization: from partial truths to a fuller picture. Br J Pharmacol. 2009;158:165-8. [PMID: 19719779]
71. Koga H, Tokunaga Y, Hisamoto T, Sujaku K, Mitsuyama K, Matsuo K, et al. Ratio of serum vascular endothelial growth factor to platelet count correlates with disease activity in a patient with POEMS syndrome. Eur J Intern Med. 2002;13:70-74. [PMID: 11836087]
72. Gherardi RK, Bélec L, Soubrier M, Malapert D, Zuber M, Viard JP, et al. Overproduction of proinflammatory cytokines imbalanced by their antagonists in POEMS syndrome. Blood. 1996;87:1458-65. [PMID: 8608236]
73. Soubrier M, Sauron C, Souweine B, Larroche C, Wechsler B, Guillevin L, et al. Growth factors and proinflammatory cytokines in the renal involvement of POEMS syndrome. Am J Kidney Dis. 1999;34:633-8. [PMID: 10516342]
74. Kuwabara S, Misawa S, Kanai K, Sawai S, Hattori T, Nishimura M, et al. Thalidomide reduces serum VEGF levels and improves peripheral neuropathy in POEMS syndrome. J Neurol Neurosurg Psychiatry. 2008;79:1255-7. [PMID: 18469028]
75. Staak JO, Glossmann JP, Esser JM, Diehl V, Mietz H, Josting A. Thalidomide for systemic capillary leak syndrome [Letter]. Am J Med. 2003;115:332-4. [PMID: 12967704]
76. Dybowski F, Sepp N, Bergerhausen HJ, Braun J. Successful use of anakinra to treat refractory Schnitzler's syndrome. Clin Exp Rheumatol. 2008;26:354-7. [PMID: 18565263]
77. Crouch R, Akhras V, Sarkany R. Schnitzler's syndrome: successful treatment with anakinra. Australas J Dermatol. 2007;48:178-81. [PMID: 17680970]
78. Lust JA, Lacy MQ, Zeldenrust SR, Dispenzieri A, Gertz MA, Witzig TE, et al. Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1{beta}-induced interleukin 6 production and the myeloma proliferative component. Mayo Clin Proc. 2009;84:114-22. [PMID: 19181644]
79. Teelucksingh S, Padfield PL, Edwards CR. Systemic capillary leak syndrome. Q J Med. 1990;75:515-24. [PMID: 2201996]
80. Zeng L, Xu H, Chew TL, Eng E, Sadeghi MM, Adler S, et al. HMG CoA reductase inhibition modulates VEGF-induced endothelial cell hyperpermeability by preventing RhoA activation and myosin regulatory light chain phosphorylation. FASEB J. 2005;19:1845-7. [PMID: 16160062]
81. Li J, Wang JJ, Chen D, Mott R, Yu Q, Ma JX, et al. Systemic administration of HMG-CoA reductase inhibitor protects the blood-retinal barrier and ameliorates retinal inflammation in type 2 diabetes. Exp Eye Res. 2009;89:71-8. [PMID: 19254713]
82. Jacobson JR, Barnard JW, Grigoryev DN, Ma SF, Tuder RM, Garcia JG. Simvastatin attenuates vascular leak and inflammation in murine inflammatory lung injury. Am J Physiol Lung Cell Mol Physiol. 2005;288:L1026-32. [PMID: 15665042]
83. Dell'Omo G, Bandinelli S, Penno G, Pedrinelli R, Mariani M. Simvastatin, capillary permeability, and acetylcholine-mediated vasomotion in atherosclerotic, hypercholesterolemic men. Clin Pharmacol Ther. 2000;68:427-34. [PMID: 11061583]
84. Jensen BM, Beaven MA, Iwaki S, Metcalfe DD, Gilfillan AM. Concurrent inhibition of kit- and FcepsilonRI-mediated signaling: coordinated suppression of mast cell activation. J Pharmacol Exp Ther. 2008;324:128-38. [PMID: 17925481]
85. Brunton VG, Frame MC. Src and focal adhesion kinase as therapeutic targets in cancer. Curr Opin Pharmacol. 2008;8:427-32. [PMID: 18625340]
86. Eliceiri BP, Paul R, Schwartzberg PL, Hood JD, Leng J, Cheresh DA. Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Mol Cell. 1999;4:915-24. [PMID: 10635317]
87. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med. 2003;9:669-76. [PMID: 12778165]
88. Kümpers P, David S, Haubitz M, Hellpap J, Horn R, Bröcker V, et al. The Tie2 receptor antagonist angiopoietin 2 facilitates vascular inflammation in systemic lupus erythematosus. Ann Rheum Dis. 2009;68:1638-43. [PMID: 18930996]
89. Yang ZY, Duckers HJ, Sullivan NJ, Sanchez A, Nabel EG, Nabel GJ. Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury. Nat Med. 2000;6:886-9. [PMID: 10932225]
90. Wahl-Jensen VM, Afanasieva TA, Seebach J, Ströher U, Feldmann H, Schnittler HJ. Effects of Ebola virus glycoproteins on endothelial cell activation and barrier function. J Virol. 2005;79:10442-50. [PMID: 16051836]